Highly drug/target-tolerant neutralizing antibody (NAb) assay development through target-based drug depletion and drug-based NAb extraction for an anti-EGFR therapeutic monoclonal antibody
Rongrong Fu(Liaocheng University), Qingcheng Guo(Second Military Medical University), Weizhu Qian(Institute of Molecular and Cell Biology), Sheng Hou(Second Military Medical University), Xinyi Su(Ministry of Education of the People's Republic of China), Jun Li(Sun Yat-sen University), Xiang Zhao(Liaocheng University), Jin Xu(China Pharmaceutical University), Lusha Ji(Liaocheng University), Fugui Wang(Liaocheng University), Mengjiao Xu(Fujian Medical University), Huaizu Guo, Tao Liu(Liaocheng University), Dapeng Zhang(Air Force Communication NCO Academy)
Cited by 0
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Light-harvesting chlorophyll a/b-binding proteins, positively involved in abscisic acid signalling, require a transcription repressor, WRKY40, to balance their function
|Journal of Experimental Botany|2013|178
MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production
|PLoS neglected tropical diseases|2014|87
Apigenin remodels the gut microbiota to ameliorate ulcerative colitis
|Frontiers in Nutrition|2022|64
Impact of Microplastics on the Ocular Surface
|International Journal of Molecular Sciences|2023|39